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Abstract: Calibration of a three-dimensional multimodal digital breast 
tomosynthesis (DBT) x-ray and non-fiber based near infrared spectral 
tomography (NIRST) system is challenging but essential for clinical 
studies. Phantom imaging results yielded linear contrast recovery of total 
hemoglobin (HbT) concentration for cylindrical inclusions of 15 mm, 10 
mm and 7 mm with a 3.5% decrease in the HbT estimate for each 1 cm 
increase in inclusion depth. A clinical exam of a patient’s breast containing 
both benign and malignant lesions was successfully imaged, with greater 
HbT was found in the malignancy relative to the benign abnormality and 
fibroglandular regions (11 μM vs. 9.5 μM). Tools developed improved 
imaging system characterization and optimization of signal quality, which 
will ultimately improve patient selection and subsequent clinical trial 
results. 
©2015 Optical Society of America 
OCIS codes: (120.3890) Medical optics instrumentation; (170.0110) Imaging systems; 
(170.3830) Mammography 
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1. Introduction 
Development of a three-dimensional non-fiber based optical imaging system co-registered 
with a clinical modality requires calibration prior to clinical data collection in order to 
validate the imaging data. Calibration is a multi-step and continuous process that includes 
hardware component testing, data simulation, phantom experimentation and patient image 
analysis. It is essential for any imaging system intended for clinical use. Multi-modality 
imaging techniques present some additional challenges associated with data co-registration. 
Near-infrared (NIR) spectral tomography (NIRST) uses light (600-1000nm) that is 
preferentially absorbed by endogenous tissue metabolic markers hemoglobin, water, and 
lipids that are often altered in the presence of malignancy [1–5]. NIRST alone suffers from 
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low spatial resolution so it can be synergistically combined with detailed anatomic 
information from digital breast tomosynthesis (DBT). DBT is an x-ray based breast imaging 
technique approved by the FDA for breast cancer screening. It is highly spatially resolved in-
plane, but the limited angle of source-detector rotation leads to partial volume averaging that 
reduces resolution parallel to the x-ray beam substantially. Thus, the resulting images have 
superb resolution in the directions perpendicular to the x-ray beam, but resolution parallel or 
axial to the plane is about ten times worse in the case of the NIRST/DBT system investigated 
here, as illustrated in Fig. 1 [6]. Hence, in the case of NIRST/DBT where DBT-derived 
regions-of-interest (ROIs) are incorporated into NIRST image reconstruction, the effects of (i) 
mischaracterization of the depth of an inclusion and (ii) under- or over-estimation of its 
volume need to be investigated. 
Additionally, challenges are posed by combining the optical acquisition in the same 
geometry as the DBT which are different from previously reported multimodal integrations of 
optical imaging. One combination of DBT and NIR optical imaging has already demonstrated 
clinical success in distinguishing benign from malignant lesions [1]; however, the images 
were not co-registered for utilization of spatial priors in the optical image reconstruction. 
Ultrasound has been successfully coupled with NIR light [7,8], but in a reflectance geometry. 
Other combinations of NIR with MRI have appeared [9–12], but these systems incorporate 
fiducial markers to localize optical sources and detectors. 
In our NIRST/DBT platform, the light source is not directly in contact with the breast – 
rather light is directed towards the tissue with mirrors as described in detail elsewhere 
[13,14]. This approach is less costly and allows an unlimited number of source positions to be 
used with arbitrary selection of locations, but correctly identifying each source position on the 
breast surface is more challenging. 
In this paper, calibration and phantom studies are used to assess NIRST/DBT for co-
registration of spatial locations between the two imaging systems, the effects of depth and 
volume mischaracterization of ROIs, and determination of the size and contrast resolution 
limits of the integrated imaging platform. These studies were facilitated by layered phantoms 
rapidly constructed from a series of slabs, one of which incorporated inclusions of different 
sizes and contrasts, that dramatically reduced the time and effort involved in the experimental 
system performance characterization. An example result from a clinical case is shown to 
demonstrate the utility of the phantom studies for system calibration and performance 
evaluation. 
2. Materials and methods 
2.1 Imaging system 
The NIRST/DBT imaging system was a modified Hologic© Genesis prototype research DBT 
unit with integrated optical components developed at Dartmouth. Eight wavelengths between 
661 and 940 nm were raster scanned at 1, 1.5, or 2 cm intervals across the top of the phantom 
with a detector panel comprised of seventy-five 1 cm x 1 cm photodiodes placed beneath the 
phantom for signal detection. Additional details on the imaging system can be found in prior 
publications [13,14] and it is shown in Fig. 1. 
2.2 Source and detector localization 
NIRST sources were placed on top of a phantom after directly visualization of the light 
source and metal markers placed at their most central location as shown in Fig. 2 for the most 
central source as well as the sources marking the corner of the rectangle. Afterwards, x-ray 
images were acquired of the metal markers and the detector panel. The DBT projections were 
reconstructed and slices corresponding to the depth of the source and detectors were analyzed. 
The source and detector central positions were correlated to the nearest DBT image pixel to 
ensure that the optical and x-ray data were completely co-registered. The source positions had 
been previously measured at a different phantom height with a 2 cm spacing between each 
source and those measurements were extrapolated for all heights using simple geometric 
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formulas to maintain constant position regardless of height. The detector positions had been 
modeled based on actual measurements of the detector panel. Average difference between the 
source position measured on DBT and the modeled source position was 3.0 mm while the 
average difference between the detector position on DBT and the modeled detector position 
was 2.2 mm with lower differences near the center of the field (2.5 mm and 1.5 mm for 
sources and detectors respectively). 
2.3 Phantom design 
 
Fig. 1. (a) Photograph of the spectrally varying resin phantom slab used in the experiments. (b) 
DBT image slice of an invasive ductal carcinoma in the plane perpendicular to the x-ray beam. 
Tumor location is indicated with a white arrow. (c) Photograph of the DBT/NIRST imaging 
system patient interface. (d) DBT slice from same breast as (b) is shown in the parallel plane 
with the locations of the slice and tumor in (b) indicated by the red and green lines, 
respectively. (e) Photograph of the NIRST detector panel placed under the breast inside a 
specially designed polycarbonate case that can be removed during the procedure. 
A layered phantom construction, shown in Fig. 1, was used for optical calibration studies. It 
was comprised of 18 x 26 cm x 1-2 cm slabs of a proprietary hard resin created by INO 
(Institut National D’Optique, Quebec City, CAN) with spectral variations in μa (0.03-0.06 
mm−1) and μs’ (0.9-1.0 mm−1), similar to the measured properties of breast tissue [15]. Optical 
properties were measured by INO at two wavelengths (740 nm and 785 nm) and calculated 
for the remaining wavelengths available in the NIRST/DBT system [16]. Slabs were either 1 
cm or 2 cm in thickness and stacked in different orders and orientations to create a suite of 
geometries and optical properties. The 2 cm slab had cylindrical holes of different sizes to 
represent inclusions – a large hole of 1.5 cm diameter and 1.5 cm height, a medium hole of 1 
cm diameter and 1 cm height, and a small hole of 0.7 cm in diameter and 0.7 cm in height. 
Slabs were arranged to mimic a lesion at four different depths and two different locations by 
changing the order of (and rotating) the layer with asymmetrically-placed holes. The 
composite phantom thickness was 6 cm, which is larger than the mean breast thickness of 5.3 
cm for cranio-caudal breast mammography [17]. When only the homogeneous slabs were 
included, the phantom was used as a reference for calibration of clinical exams. 
2.4 Inclusion measurements 
The phantom was imaged in the NIRST/DBT system after a fixed liquid volume was pipetted 
into each small hole, starting with the lowest blood concentration (15 μM) which was 
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sequentially increased (by 15 μM) to a maximum of 60 μM. The liquid injected into each 
inclusion was comprised of 1.15% intralipid to approximate the scattering of the resin 
phantom, and included carefully measured concentrations of porcine blood and water. For a 
given set of inclusion positions, the slab containing the inclusion holes was not moved during 
sequential image acquisitions for each contrast level injection (subsequent inclusion 
position/depth changes did require slab reconfiguration followed by another series of contrast 
injections in the newly constructed, composite phantom which then remained stationary). 
2.5 Data calibration 
Data calibration consists of four steps: assigning the optical properties of the homogeneous 
reference phantom, altering the measured data based on attenuator settings, wavelength by 
wavelength reconstructions comparing the measured phantom data with simulated results 
using the known optical properties of the phantom and applying correction factors to the 
breast data. Lastly, generation of a homogenous initial guess for region based reconstruction 
of the breast data is completed. The calibration process involves a finite element mesh for the 
phantom and a different mesh for the breast so that exact matching of thicknesses is 
unnecessary. This initial guess is used for a wavelength by wavelength reconstruction hard 
priors guided reconstruction, leading to a single value obtained for each of the labeled 
regions. Only absorption is recovered, scattering for the phantom is obtained from initial 
measurements performed by INO. 
2.6 Data reconstruction 
 
Fig. 2. DBT reconstruction slice corresponding to the height of the top of the optical phantom 
(left) with arrows pointing to metal markers of a few directly visualized source positions with 
the source positions marked in red. A DBT slice corresponding to the level of the detectors 
(right) with blue markings at the modeled detector locations. Graph shows dependence of 
inclusion HbT estimates with decreasing regularization. 
The NIRFAST software package was used to reconstruct total hemoglobin (HbT) 
concentration images using a finite element method (FEM) technique [18,19]. FEM meshes 
representing the homogeneous and contrast phantoms were created using a three-dimensional 
(3D) algorithm that allowed higher node density in user-defined areas of interest. For each 
imaging geometry, meshes were created from the measured dimensions of the phantom, and 
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were refined in the inclusion regions to have a nodal spacing of 0.8 mm relative to 2.5 mm for 
the remainder of the background volume. The data set recorded for the lowest HbT (15 μM) 
was used for calibration since the hemoglobin absorption was similar to the resin at this 
concentration. The four most stable wavelengths - 660, 808, 830 and 852 nm – were used (the 
other wavelengths were less stable) and spectral image recovery was performed after the 
images for the individual wavelengths were reconstructed. Water and lipid contents were not 
assessed because of their non-physiological levels in the resin background and inclusions, and 
the elimination of higher wavelengths of data due to the lower stability of the light source 
under these illumination conditions. 
Small regularization values were used to recover HbT for all the inclusions (30 μM) as 
shown in Fig. 2 because noise levels were low and the reference phantom was similar to the 
anomaly phantom. Smaller lesions required lower regularization values; in this case, 10−6 was 
necessary to fully recover the smallest inclusion, while 10−4 recovered HbT in the largest 
inclusion. All reconstructions applied prior knowledge on the size and location of the 
inclusions which stabilized the inversion and improved the reconstruction accuracy similarly 
to NIRST/MRI [11]. 
2.7 Clinical case 
The 51 year old postmenopausal patient was enrolled in an institutional review board (IRB)-
approved study after suspicious breast lesions were noted during routine screening 
mammography. The patient underwent NIRST/DBT scans of both the left and right breasts in 
cranio-caudal positioning. A calibration data set was obtained from the 2 cm homogenous 
section of the phantom without inclusions combined with the four homogeneous 1 cm slabs. 
DBT images were read by a breast radiologist (SPP), who outlined two regions of interest 
(ROIs) in the left breast. DBT images were segmented into adipose, fibroglandular, and two 
ROIs using software developed for DBT breast segmentation [20,21]. Parallel plane extension 
of the ROIs was assigned to be equal to the largest diameter of the lesions measured in the 
plane perpendicular to the x-ray beam. These segmented images were used as the basis for 
FEM mesh creation, and a higher node density was deployed in the two ROIs compared to the 
adipose and fibroglandular regions. Data measured within 15 mm of the breast periphery, 
outside the breast, or more than two standard deviations from a best-fit line of signal decrease 
with detector distance were removed prior to image reconstruction. Scattering was obtained 
from another near infrared imaging system with frequency domain capabilities [22]. After a 
wavelength-by-wavelength calibration of the data, a spectrally constrained algorithm within 
NIRFAST was used to calculate hemoglobin, oxygen saturation, water, and lipid fractions 
[23]. A single scattering average was obtained from the bulk breast tissue measurement 
performed using a different frequency domain imaging system. After a wavelength-by-
wavelength calibration of the data, a spectrally constrained algorithm within NIRFAST was 
used to calculate hemoglobin, oxygen saturation, water, and lipid fractions [23]. This method 
has shown to have increased accuracy and couldn’t be used in the case of the phantom 
imaging due to the presence of a nonphysiologic resin material [23]. The suspicious lesions 
were subsequently biopsied and the results were correlated with the NIRST/DBT image data. 
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3. Results 
3.1 Depth dependence 
 
Fig. 3. Graphs depicting hemoglobin recovery vs. actual hemoglobin concentration for the 
background and inclusions of different sizes at three different depths. Pictorial demonstrations 
of the phantom set up are shown above each graph. The slab with inclusions was 2 cm thick 
and slabs without inclusions were 1 cm thick 
Hemoglobin concentrations in inclusions placed at different depths showed linear recovery of 
about 70% of the actual values on average as shown in Fig. 3. Estimates in the largest (15 
mm) and medium (10 mm) sized inclusions demonstrated a linear response regardless of 
depth, whereas linearity was maintained in the smallest (7 mm) inclusion only at the 
shallowest depth. The 7 mm inclusion was more susceptible to small position shifts, which 
may have caused the consistently lower concentration values at the larger depths. 
Additionally, fluctuations in source strength may have introduced variability in the estimates 
for the smallest inclusion at the greatest depth because the signal disturbances caused by the 
optical heterogeneity were also very small. 
 
Fig. 4. Data from a phantom with actual inclusions positioned below a 1 cm slab on the top of 
the phantom (left picture) but modeled as below 2 cm of homogeneous background (right 
picture). The hemoglobin estimates are plotted (right graph) and can be compared with the left 
graph in Fig. 3, which uses the same data but correctly models the inclusion depths. 
Mischaracterization of inclusion depth from segmentation errors caused by poor axial 
resolution in the DBT scans was evaluated by misplacing the inclusion locations (i.e. 
inclusions were segmented as being 1 cm deeper than their actual positions). These results, 
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shown in Fig. 4, indicate a reduction in the recovered hemoglobin of 10-20% relative to the 
values in Fig. 3. Hence, mislocalization of a breast lesion may cause differences in HbT 
recovery of up to 20% (lower in the case where the segmented region is deeper than its true 
position by ~1 cm). 
3.2 Volume mischaracterization 
 
Fig. 5. Effects of volume mischaracterization when inclusions were positioned 1 cm and 2.5 
cm below the top of the phantom. Pictures above each plot indicate the modeling performed: 
overestimation of the volume of inclusions by 50% (left), true volume of inclusions (middle), 
and underestimation of the volume of inclusions by 50% (right). 
Table 1. Effects of inclusion size on the percent of actual hemoglobin recovered 
Inclusion Size Underestimated Normal Overestimated 
Large 96.3 59.5 56.0 
Medium 97.2 64.1 60.1 
Small 74.0 67.7 60.8 
Table 2. Effects of concentration on the percent of actual hemoglobin recovered 
Concentration Underestimated Normal Overestimated 
30 μM 85.0 70.5 66.2 
45 μM 91.6 63.0 58.6 
60 μM 90.8 57.7 52.1 
To investigate the impact of errors in volume introduced by poor resolution along the x-ray 
source to detector direction, inclusions were extended by 50% of their volume in height in 
one instance, and shrunk by 50% in another. In all cases, the average depth of inclusions 
remained the same. Figure 5 shows that the responses in the HbT estimates are similar (except 
for the 7 mm inclusion in the underestimated case) for the three volume assumptions, 
although the actual concentration values vary to some extent. 
For the overestimated volumes, the inclusions included some actual background; thus, the 
average contents in the inclusions were lower in HbT because the background possessed 
lower HbT. Conversely, for the underestimated volumes, portions of the inclusions were 
mischaracterized as background. Here, the recovered HbT was not altered in the much larger 
background; instead, greater signal attenuation was attributed to a smaller inclusion region 
leading to higher HbT recovery. The small inclusion behaved less systematically because its 
volume became very small, and reduced optical measurement sensitivity in the 
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underestimated case. Overall, there was no correlation between inclusion size and recovery, 
nor was there one between the HbT concentration and the percent of actual HbT recovered as 
demonstrated. 
 
Fig. 6. A portion of the background was designated as a possible region of interest shown in 
purple), modeled and reconstructed along with the actual inclusions and background. Results 
for this false inclusion were similar to the background as shown in the graph (right). 
To investigate whether contrast was caused by the specialized meshing of the inclusions, an 
additional region that was not present in the experimental phantom configurations was added 
to the model as shown in Fig. 6 and was created with the same volume and mesh resolution as 
the smallest inclusion. The hemoglobin levels recovered in this region were very close to 
those of the background, and did not vary with different HbT concentrations in the actual 
inclusions. These results indicate that a false positive finding is unlikely to occur, i.e., that a 
region in a DBT image that was labeled as suspicious but actually had no greater HbT content 
than the background would not likely appear to have a higher concentration. 
3.3 Clinical case 
 
Fig. 7. (a) DBT slice for a patient with benign (left arrow) and malignant (right arrow) lesions. 
(b) DBT image stack was segmented into adipose, fibroglandular (FG) and two ROIs. (c) Total 
hemoglobin concentration and oxygen saturation obtained from the NIRST/DBT recovery for 
each region. 
Initial clinical results from a patient with malignant pathology imaged on the NIRST/DBT 
system are shown in Fig. 7. After imaging, the patient underwent biopsies for suspicious 
lesions; one demonstrated invasive ductal carcinoma and the second, benign sclerosing 
adenosis. The NIRST/DBT results for this subject demonstrate increased HbT concentration 
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in the tumor (11.3 μM), compared with the fibroglandular and benign regions (9.8 μM) as 
well as the contralateral breast (9.9 μM). Additionally, the tumor had lower oxygen 
saturation, as might be expected from the higher oxygen demands and disorganized 
vasculature typically found in tumors [10], [24]. This clinical example nicely illustrates a case 
where the NIRST/DBT system successfully distinguished benign from malignant lesions in 
the same breast. 
4. Discussion 
Custom-designed rectangular resin-based phantom slab with spectrally varying absorption 
profiles are durable and easy to use, and offer an ability to create multiple configurations for 
assessing inclusion size, contrast, and depth dependence in optical images acquired with a 
DBT-guided NIRST system. In repeatability experiments, the same inclusion phantom was 
measured seven times without movement (data not shown). Mean variation in the estimated 
HbT in the background, large, medium, and small inclusions were calculated to be 0.5%, 
5.2%, 13.3% and 13.4%, respectively. Sources of error were attributed to short-term shifts in 
source strength and detector sensitivity. In the large background region, almost no changes 
occurred in HbT as small fluctuations were averaged over a large number of data points. 
However, greater variation was found in the inclusion estimates because their measurement 
sensitivity was limited to a small number of sources and detectors, depending on their 
locations. Hence, small shifts in source strength corresponded to more variation in recovered 
HbT concentrations, especially for smaller ROIs (inclusions). 
Hemoglobin contrast recovery was linear at all depths examined and for all inclusion sizes 
except the smallest (7 mm in height and depth). The smallest inclusion was more easily 
affected by changes in signal variation from the laser source, positioning errors, and the 
limited number of nodes created by the meshing process. Calibration showed source strength 
variations on the order of 0.5-4% depending on the laser diode. Unfortunately, when 
measuring small inclusions in a large phantom, changes in signal attenuation for the smallest 
inclusion at source and detector pairs nearest its location are only a few percent as well. For 
example, in the case of the 7 mm inclusion, a 3% difference in signal attenuation was detected 
for the highest contrast and the closest source detector pair relative to the homogeneous case, 
and is close to the size limit for contrast imaging with the current NIRST/DBT system. 
Inclusions closer to the surface were recovered with higher concentrations than those in 
the middle of the phantom. Mischaracterization of depth led to decreases in chromophore 
recovery of 10-20% in a region of interest. However, the effects were much less than those 
caused by over- or under-estimation of inclusion volume which caused variations in HbT 
estimates of 15-50%. 
Breast DBT segmentation for NIRST will benefit from these results, as accurate 
segmentation of tissue structures is important for recovering the correct HbT concentrations. 
However, a phantom has distinct boundaries, whereas ROIs in breast tissue can have much 
more uncertainty. In manual DBT segmentation, the radiologist defines the boundaries of the 
ROI, and a prior study with 173 lesions indicated that DBT overestimates the size by 1 cm in 
14.5% of lesions and underestimates the size by 1 cm in 5% of lesions compared to pathology 
[25]. In another study, where 133/149 (89%) lesions were visualized by DBT, size 
measurements for 34/133 (26%) lesions were either under- or over-estimated (17 lesions 
each) by 5 mm compared to pathology [26]. The radiologist’s measurements are based on the 
longest axis of the tumor, so total volume estimates are likely to have larger margins of error. 
Determining the extent of the tumor in the axial direction is particularly challenging when 
partial volume averaging can cause the lesion appear throughout nearly the entire axial span 
of the DBT images. However, Doppler ultrasound has shown that regions of increased 
vascularity often occur outside of the defined tumor area [27], so overestimation of the tumor 
boundaries may not lead to an overall decrease in hemoglobin recovery. Although 
segmentation errors will occur when determining the boundaries of an ROI, the effects of 
such errors are likely to be less in breast tissue relative to phantoms because of the lack of 
rigid boundaries. Any volume overestimation will result in an averaging of tissue, which can 
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lower contrast recovery if the surrounding region is not highly vascularized. Tumor volume 
underestimations can result in higher-than-expected tumor contrast if the region surrounding 
the tumor is large and non-absorbing. 
The potential of NIRST/DBT to distinguish small benign regions from malignant ROIs 
was demonstrated through the false inclusion phantom experiment as well as a clinical 
example. In the phantom case, the false ROI was defined in the same way as the other 
inclusions, but it was merely a section of the resin background. The HbT estimate in this 
region was similar to the background (14-16μM vs. 15μM for the background, within 7.5% of 
the actual value for a small lesion, less than the acceptable 13.4% natural variation from the 
repeatability studies), standard deviation < 1μM across all measurements, suggesting that the 
meshing and image reconstruction process are unlikely to cause false positive results. The 
argument was further supported by the clinical case, which showed elevated HbT (11.3 μM) 
in a malignant tumor compared to a benign lesion (9.8 μM). The difference between the 
benign and malignant lesion is 15%, greater than the variability shown in phantom 
experiments for similarly sized lesions (5.2%). Hence it is unlikely that this 15% difference 
could be attributed to measurement variability and demonstrates a true difference between the 
two tissue types 
4. Conclusions 
NIRST/DBT imaging of the breast faces several challenges related to extraction of DBT 
anatomical priors and the expected size of suspicious ROIs detected on a screening exam. 
Creation of systematic calibration and co-registration processes, and construction of a 
durable, heterogeneous phantom that can be configured in many different ways facilitated 
determination of the imaging limitations of the new platform. The phantom was easy to use 
and clean, and is long-lasting and durable. Significantly less time was required to perform 
experiments with this phantom relative to other methods for creating heterogeneous 
phantoms. 
Linear recovery of HbT occurred for cylindrical inclusions measuring 7 mm, 10 mm and 
15 mm in diameter and height in most cases. HbT concentration estimates were similar for the 
two larger inclusions, but values were lower for the smallest ROI in some situations. 
Quantitative recovery was affected by the depth of the inclusion within the phantom, 
mischaracterization of its depth, and most significantly, under or overestimation of its 
volume. The NIRST/DBT system was capable of distinguishing real changes in HbT levels 
from an arbitrarily defined ROI in the background without contrast, and also distinguished 
benign from malignant lesions in vivo of sizes similar to, or smaller than, what would 
normally be detected through mammographic images. 
Phantoms similar to the ones described here could be used in the development of any 
optical imaging system to improve signal-to-noise ratios, and/or assess imaging performance 
or calibrate source/detector signals. The outcomes of such phantom experiments guide patient 
selection and optimize efficiency, and increase the likelihood of obtaining significant clinical 
results in the future. 
The results described here will be essential in future clinical studies. Based on these 
results, it is possible to detect tumors at least as small as 7mm, about half the size of tumors 
normally detected in a screening population [28]. During patient exams, efforts will be made 
to position tumors centrally within the breast to minimize errors from positioning. Expanding 
tumor areas to include an additional 3mm boundary to account for any positioning uncertainty 
may improve chromophore recovery. Additionally, thresholds for distinguishing benign from 
malignant lesions can be estimated based on the variability measurements from this phantom 
work and differences from the background of less than 13.5% may be the threshold for 
assessing benign from malignant status. 
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